Teun van Gelder

Professor in Drug Discovery & Development

Leiden University Medical Center

Netherlands

Research Interests

Explore related searches

Professors in Netherlands

Contact this professor

ORCID

Google Scholar

About

Teun van Gelder is a Professor in Drug Discovery & Development at Leiden University Medical Center in the Netherlands. His research focuses on therapeutic drug monitoring, medication-related health literacy, and drug interactions, particularly in relation to kidney transplantation and cancer treatments. Recent publications by Professor van Gelder address various factors influencing drug exposure and clinical outcomes, as well as the implementation of medication management strategies.

Teun van Gelder

Research Interests

Explore related searches

Contact this professor

About

Articles (18)

Medication-related health literacy in patients on hemodialysis assessed with the RALPH interview guide

Algorithm-managed dosing and pharmacist-managed dosing of erythropoietin stimulating agents in renal anaemia: a systematic review

Barriers and facilitators for effective sick day guidance implementation

Exploring the Association Between Intra‐Patient Variability in Trough Concentration of Pazopanib and Clinical Outcomes in Renal Cell Carcinoma and Soft Tissue Sarcoma Patients

Should we abandon therapeutic drug monitoring of tacrolimus in whole blood and move to intracellular concentration measurements?

Therapeutic drug monitoring of tacrolimus after kidney transplantation: trough concentration or area under curve‐based monitoring?

An Integrated Approach for Representing Knowledge on the Potential of Drugs to Cause Acute Kidney Injury

The effect of genetic variants in the transcription factor TSPYL family on the CYP3A4 mediated cyclosporine metabolism in kidney transplant patients

Development and Bioequivalence of 3D‐Printed Medication at the Point‐of‐Care: Bridging the Gap Toward Personalized Medicine

Mycophenolic Acid Exposure Determines Antibody Formation Following SARS‐CoV‐2 Vaccination in Kidney Transplant Recipients: A Nested Cohort Study

Tacrolimus and Mycophenolic Acid Exposure Are Associated with Biopsy‐Proven Acute Rejection: A Study to Provide Evidence for Longer‐Term Target Ranges

The Appropriately Designed TDM Clinical Trial: Endpoints, Pitfalls, and Perspectives

Sex Differences in Spironolactone and the Active Metabolite Canrenone Concentrations and Adherence

Dynamics of the QTc interval over a 24‐h dose interval after start of intravenous ciprofloxacin or low‐dose erythromycin administration in ICU patients

How cyclosporine reduces mycophenolic acid exposure by 40% while other calcineurin inhibitors do not

Model-informed precision dosing to optimise immunosuppressive therapy in renal transplantation

Machine Learning as a Novel Method to Support Therapeutic Drug Management and Precision Dosing

Avoiding Tacrolimus Underexposure and Overexposure with a Dosing Algorithm for Renal Transplant Recipients: A Single Arm Prospective Intervention Trial

Collaborators (7)

Dirk Jan A. R. Moes

Patricia Van den Bemt

Kirsten J. M. Schimmel

Brenda de Winter

Aiko P. J. de Vries

Henk-Jan Guchelaar

Jesse Swen

How do I reach out?

Meet Kite AI